Member Info for travel_light

Avacta on Twitter has interview.

Similar to meeting this week. LFD widespread home use next year. Pilot batch is still work in progress.

why do you think it will be 1 billion ?

Al probably knows the worth to a big pharma company, and if this was actual would know how to get more offers on table.

Guardian article was about capacity being secured for poor, so they don’t get outbid due to what will be a shortage for everyone.

I agree with Numpty, it’s PLs fault

I would have thought 2 degrees and 30 years of experience would have produced a timeline that was a little better than the one produced by a chimp with a dartboard. Well we all live and learn (or not as the case maybe).

There is a book open offering odds at 20:1 that an apology is forthcoming with an acknowledgement that it was all similar to the stuff coming out of bulls rear ends. Think the odds need to be higher to take that bet.

Going to Q and A

Travel light signing off

Pilot batch is a process.

10,000 units

Soon as ready timing will be given

Stressing tech transfer is done right so that clinical validation is smooth

Robust reliable words used

Liverpool design end user testing for consumer

Trying to work in parallel

Others looking at oem deals

Increased affimer production soon ready

Plus external partner

Affimer not bottleneck

Bbi Abington 7’al million tests per month

Need to upscale

Overseas capacity needed

Asia SE Asia ... quality due dillagence

Governments and authorities BUT CONFIDENTIAL

120 m test per month Uk only

Supply multi factor

Saliva tube, pippete

Supply is the worry

Visual test ie no machine. Very confident

Smart phone app to record result

Feed to data systems

Professional
Self cert first

Second consumer takes longer

Hospital market low cos pcr on site, but nurse in
Companies is good market for professional. Also doctors etc

Loosing this writing and listening

Presymptomatic is good????

Graph showing viral
Load verses infectious

High specificy regular testing needed

Sensitivity needed 90% or more

Basically numbers to show where value is

LFD ... do I have infection

Graph about infectioness verses having virus.

Pcr good for early but redial after recovery

7 days for antibody to late

Sweet spot when infected is most infectious

7/10 days after symptoms is where you want to see

Antigen is best

Now doing how BAMs works.

Showing a complicated mass spectrum graph. Finger print. Spot mutation.

Work has been slow trying to accelerate this with condor. Clinical validation Q4. Large commercial interests. Will goto market via mass spectrum seller

Few thousand copies of virus in saliva.

Also very specific. No cross reactivity with common simulate virus

Alister say Elisa test best on market

Dose escalation safety etc 2021

Small number till max dose established.

Range of cancers in study.

Bigger Dose study 1, or 2 cancers in 2022 on back of part A

1,5b per year, 5-10% royalty to Avacta plus dev milestones

How precision works ava6000. Clever stuff

Starts with precision. Filing q4, start late q1, initial data mid 2021